Decent Value Stocks. Analyze the stocks with a good fundamental valuation, while still showing decent profitability, health and growth.
We assign a fundamental rating of 6 out of 10 to GILD. GILD was compared to 567 industry peers in the Biotechnology industry. GILD scores excellent on profitability, but there are some minor concerns on its financial health. GILD may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make GILD suitable for value investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 0.81% | ||
ROE | 2.48% | ||
ROIC | 17.45% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 37.7% | ||
PM (TTM) | 1.67% | ||
GM | 78.26% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.29 | ||
Debt/FCF | 2.59 | ||
Altman-Z | 3.46 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.6 | ||
Quick Ratio | 1.45 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.4 | ||
Fwd PE | 12.1 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 12.53 | ||
EV/EBITDA | 10.68 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.06% |